Company Overview
About Turn Biotechnologies
Turn Biotechnologies is a longevity company using modified mRNA cocktails to transiently reprogram aged cells back toward a youthful epigenetic state — without permanently altering DNA sequences. The company has raised $29 million in Series A financing and acquired ARMMs (Arrestin Domain-Containing Protein 1 Mediated Microvesicle) technology in March 2025 to significantly upgrade the delivery capability of its mRNA reprogramming platform.
Business Model & Competitive Advantage
The mRNA reprogramming approach is designed to be reversible and transient: unlike CRISPR or viral gene therapies that make permanent changes to DNA, Turn's mRNA molecules naturally degrade after delivering their cellular reprogramming instructions. This potentially safer profile addresses one of the primary clinical concerns with epigenetic reprogramming approaches — the risk that partial reprogramming might induce inappropriate cell state changes that persist.
Competitive Landscape 2025–2026
Turn's dermatology beachhead — applying mRNA reprogramming to aged skin cells to demonstrate in vivo rejuvenation before advancing to systemic conditions — is a clinically accessible first proof point. Skin is directly observable, has established outcome metrics, and allows safety assessment without the systemic monitoring required for internal tissue reprogramming. The ARMMs acquisition significantly upgrades the mRNA delivery system, improving cellular uptake and reducing immune response to the delivery vehicle.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Turn Biotechnologies is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Not So Random Others
a2z Radiology AI
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disea
Adept AI
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and exec
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Plenty
Plenty is a San Francisco-based indoor vertical farming company that uses AI, machine learning, and robotics to grow leafy greens and other produce in controlled indoor environments. The company has r
Oura
Oura is the maker of the Oura Ring, a premium smart ring that tracks sleep, recovery, readiness, and health metrics through continuous biometric sensing. The company raised $900 million in Series E fi
Nira Energy
Nira Energy is a Denver-based renewable energy software company providing grid capacity mapping and interconnection analysis tools that help solar, battery storage, and data center developers identify
Compare Turn Biotechnologies with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Turn Biotechnologies? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Turn Biotechnologies Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Turn Biotechnologies vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →